---
figid: PMC387380__zpq0140444200006
figlink: /pmc/articles/PMC387380/figure/fig6/
number: F6
caption: Working model of potential mechanisms of DA receptor signaling and sites
  of action of the different pharmacological agents used in this study. In red, regulation
  of the Akt/GSK-3 pathway by DA. Elevated DA tones lead to activation of GSK-3 through
  a signaling cascade involving D2-class receptors and the inactivation of Akt caused
  by a reduction of its phosphorylation on Thr-308. This reduction in Akt activity
  results in a reduced phosphorylation/increased activation of GSK-3α and GSK-3β that,
  in turn, regulate DA-associated behaviors. Note that, in contrast to DARPP-32, the
  phosphorylation of Akt and GSK-3 was not affected by cAMP. Dashed lines indicate
  the effect of different drugs on this signaling cascade. D1R, DA D1 receptor; D2R,
  DA D2 receptor; AC, adenylyl cyclase.
pmcid: PMC387380
papertitle: Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen
  synthase kinase 3 signaling cascade.
reftext: Jean-Martin Beaulieu, et al. Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):5099-5104.
pmc_ranked_result_index: '72344'
pathway_score: 0.9444617
filename: zpq0140444200006.jpg
figtitle: Working model of potential mechanisms of DA receptor signaling and sites
  of action of the different pharmacological agents used in this study
year: '2004'
organisms:
- Homo sapiens
ndex: 4300d07c-def2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC387380__zpq0140444200006.html
  '@type': Dataset
  description: Working model of potential mechanisms of DA receptor signaling and
    sites of action of the different pharmacological agents used in this study. In
    red, regulation of the Akt/GSK-3 pathway by DA. Elevated DA tones lead to activation
    of GSK-3 through a signaling cascade involving D2-class receptors and the inactivation
    of Akt caused by a reduction of its phosphorylation on Thr-308. This reduction
    in Akt activity results in a reduced phosphorylation/increased activation of GSK-3α
    and GSK-3β that, in turn, regulate DA-associated behaviors. Note that, in contrast
    to DARPP-32, the phosphorylation of Akt and GSK-3 was not affected by cAMP. Dashed
    lines indicate the effect of different drugs on this signaling cascade. D1R, DA
    D1 receptor; D2R, DA D2 receptor; AC, adenylyl cyclase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ADCY1
  - ADCY3
  - GSK3B
  - ADCY6
  - ADCY7
  - AKT1
  - ADCY10
  - AKT2
  - PPP1R1B
  - GSK3A
  - ADCY2
  - ADCY5
  - PRKACG
  - ADCY9
  - ADCY8
  - PRKACB
  - PRKAR1B
  - AKT3
  - ADCY4
  - PRKAR2B
  - THRB
  - THRA
  - PRKACA
  - PRKAR2A
  - PRKAR1A
  - SCH23390
  - Dopamine
  - Ser
  - Thr
  - Raclopride
genes:
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: GSK-3a/B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: DARPP-32,
  symbol: DARPP-32
  source: hgnc_alias_symbol
  hgnc_symbol: PPP1R1B
  entrez: '84152'
- word: GSK-3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: (Thr
  symbol: THR
  source: bioentities_symbol
  hgnc_symbol: THRB
  entrez: '7068'
- word: GSK-3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: (Thr
  symbol: THR
  source: bioentities_symbol
  hgnc_symbol: THRA
  entrez: '7067'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
chemicals:
- word: SCH23390
  source: MESH
  identifier: C534628
- word: Dopamine
  source: MESH
  identifier: D004298
- word: Ser
  source: MESH
  identifier: D012694
- word: Thr
  source: MESH
  identifier: D013912
- word: Raclopride
  source: MESH
  identifier: D020891
diseases: []
figid_alias: PMC387380__F6
redirect_from: /figures/PMC387380__F6
figtype: Figure
---
